✦ LIBER ✦

Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial

✍ Scribed by Steven R. Alberts; Vera J. Suman; Henry C. Pitot; John K. Camoriano; Joseph Rubin

Book ID: 107573639
Publisher: Springer US
Year: 2007
Tongue: English
Weight: 84 KB
Volume: 38
Category: Article
ISSN: 1941-6628
DOI: 10.1007/s12029-007-9007-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A north central cancer treatment group P

A north central cancer treatment group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma

✍ Henry C. Pitot; James A. Knost; Michelle R. Mahoney; John Kugler; James E. Krook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 3 views

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor